Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 6/1997

01-09-1997 | ORIGINAL ARTICLE

Pharmacokinetics of Adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation

Authors: Y. Ku, Nobuya Kusunoki, Tetsushi Kitagawa, Ichiro Maeda, Takumi Fukumoto, Takeshi Iwasaki, Masahiro Tominaga, Yasuyuki Suzuki, Yoshikazu Kuroda, Yusuke Tanigawara, Yoichi Saitoh

Published in: Cancer Chemotherapy and Pharmacology | Issue 6/1997

Login to get access
Metadata
Title
Pharmacokinetics of Adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation
Authors
Y. Ku
Nobuya Kusunoki
Tetsushi Kitagawa
Ichiro Maeda
Takumi Fukumoto
Takeshi Iwasaki
Masahiro Tominaga
Yasuyuki Suzuki
Yoshikazu Kuroda
Yusuke Tanigawara
Yoichi Saitoh
Publication date
01-09-1997
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 6/1997
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800050687

Other articles of this Issue 6/1997

Cancer Chemotherapy and Pharmacology 6/1997 Go to the issue

ORIGINAL ARTICLE

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

ORIGINAL ARTICLE

The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study

ORGINAL ARTICLE

Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells

SHORT COMMUNICATION

Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers

ORIGINAL ARTICLE

GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol

ORIGINAL ARTICLE

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits